155 related articles for article (PubMed ID: 6883400)
1. Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide.
Campbell TJ; Vaughan Williams EM
Cardiovasc Res; 1983 May; 17(5):251-8. PubMed ID: 6883400
[TBL] [Abstract][Full Text] [Related]
2. Voltage- and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two steroidal antiarrhythmic drugs, CCI 22277 and ORG 6001.
Campbell TJ
Br J Pharmacol; 1982 Nov; 77(3):541-8. PubMed ID: 7139201
[TBL] [Abstract][Full Text] [Related]
3. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
Campbell TJ
J Cardiovasc Pharmacol; 1983; 5(2):291-6. PubMed ID: 6188905
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.
Campbell TJ
Cardiovasc Res; 1983 Jun; 17(6):344-52. PubMed ID: 6883410
[TBL] [Abstract][Full Text] [Related]
5. Rate-dependent depression of maximal rate of depolarization in guinea pig papillary muscle action potentials by changrolin.
Kuang Y; Liu TP
Zhongguo Yao Li Xue Bao; 1990 May; 11(3):225-9. PubMed ID: 2087995
[TBL] [Abstract][Full Text] [Related]
6. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
Hattori Y; Hidaka T; Aisaka K; Satoh F; Ishihara T
J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.
Sunami A; Sawanobori T; Adaniya H; Hiraoka M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258
[TBL] [Abstract][Full Text] [Related]
8. Comparison in vitro of the electrophysiological effects of lorcainide and its metabolite norlorcainide.
Carmeliet E
Eur J Pharmacol; 1987 Jan; 133(1):29-36. PubMed ID: 3556390
[TBL] [Abstract][Full Text] [Related]
9. Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.
Hemsworth PD; Campbell TJ
Br J Pharmacol; 1989 Jun; 97(2):619-25. PubMed ID: 2503225
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of a new antiarrhythmic agent, lorcainide, on the isolated cardiac muscle fiber as compared with disopyramide.
Shigenobu K; Atoda H; Asano T; Kasuya Y
J Pharmacobiodyn; 1980 Dec; 3(12):677-85. PubMed ID: 7277183
[TBL] [Abstract][Full Text] [Related]
11. Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.
Hasegawa J; Hirai S; Noguchi N; Hisatome I; Kotake H; Mashiba H
Br J Pharmacol; 1990 Apr; 99(4):815-9. PubMed ID: 2361175
[TBL] [Abstract][Full Text] [Related]
12. Cellular electrophysiological properties of a new aminosteroid antiarrhythmic agent, SC-35135.
Borowicz LE; Martin CL; Sanguinetti MC
J Cardiovasc Pharmacol; 1988 Aug; 12(2):218-26. PubMed ID: 2459553
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of SD-3212, a new antiarrhythmic agent with vasodilator action, on guinea-pig ventricular cells.
Kodama I; Suzuki R; Maruyama K; Toyama J
Br J Pharmacol; 1995 Jan; 114(2):503-9. PubMed ID: 7881749
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmogenic effects of toxic concentrations of the antiarrhythmic drug lorcainide on the isolated canine ventricle.
Senges J; Rizos I; Brachmann J; Gao TL; Lengfelder W; Kübler W
J Pharmacol Exp Ther; 1982 Nov; 223(2):547-51. PubMed ID: 7131303
[TBL] [Abstract][Full Text] [Related]
15. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
Camm AJ
Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
[No Abstract] [Full Text] [Related]
16. Effects of BW A256C, a novel class 1 antiarrhythmic agent, on maximum rate of depolarisation of cardiac action potentials in vitro: frequency, use, and voltage dependence.
Donoghue S; Payne PN; Allan G
J Cardiovasc Pharmacol; 1987 Jan; 9(1):12-8. PubMed ID: 2434786
[TBL] [Abstract][Full Text] [Related]
17. Frequency dependent effects of tocainide, quinidine, and flecainide on conduction as reflected in the rise time of the monophasic action potential in the isolated guinea pig heart.
Duker BG
Cardiovasc Res; 1991 Mar; 25(3):217-22. PubMed ID: 1903081
[TBL] [Abstract][Full Text] [Related]
18. Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles.
Valenzuela C; Delpón E; Tamargo J
J Cardiovasc Pharmacol; 1988 Oct; 12(4):423-31. PubMed ID: 2465442
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of AFD-21 and AFD-19, new antiarrhythmic compounds on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
Kodama I; Kamiya K; Kawamura T; Suzuki R; Toyama J
Br J Pharmacol; 1990 Dec; 101(4):803-8. PubMed ID: 2085705
[TBL] [Abstract][Full Text] [Related]
20. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Wu B; Sato T; Kiyosue T; Arita M
Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
